BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3968641)

  • 1. Amphetamine attenuates the stimulated release of dopamine in vivo.
    Kuhr WG; Ewing AG; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1985 Feb; 232(2):388-94. PubMed ID: 3968641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.
    Kamal LA; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evoked neuronal activity accompanied by transmitter release increases oxygen concentration in rat striatum in vivo but not in vitro.
    Zimmerman JB; Kennedy RT; Wightman RM
    J Cereb Blood Flow Metab; 1992 Jul; 12(4):629-37. PubMed ID: 1618942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL; Berkowitz AL; Regenstein AC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reserpine inhibits amphetamine action in ventral midbrain culture.
    Sulzer D; St Remy C; Rayport S
    Mol Pharmacol; 1996 Feb; 49(2):338-42. PubMed ID: 8632767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
    Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat.
    Nieoullon A; Cheramy A; Leviel V; Glowinski J
    Eur J Pharmacol; 1979 Jan; 53(3):289-96. PubMed ID: 32060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
    May LJ; Kuhr WG; Wightman RM
    J Neurochem; 1988 Oct; 51(4):1060-9. PubMed ID: 2971098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum.
    Wagner AK; Sokoloski JE; Ren D; Chen X; Khan AS; Zafonte RD; Michael AC; Dixon CE
    J Neurochem; 2005 Oct; 95(2):457-65. PubMed ID: 16190869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S; Aono Y; Fusa K; Takada K; Saigusa T; Koshikawa N; Cools AR
    Neuroscience; 2005; 136(1):251-7. PubMed ID: 16181742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
    Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
    Suaud-Chagny MF; Buda M; Gonon FG
    Eur J Pharmacol; 1989 May; 164(2):273-83. PubMed ID: 2788097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry.
    Cadoni C; Pinna A; Russi G; Consolo S; Di Chiara G
    Neuroscience; 1995 Apr; 65(4):1027-39. PubMed ID: 7617159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.